Jobs / United States / 4D Molecular Therapeutics INC

4D Molecular Therapeutics INC

Clinical Research Associate (Contract)

Emeryville, California Posted today

Apply on employer site ↗ Tailor my CV first Source: Company careers site

Optional: we can tailor a CV and cover letter for this job from your real experience first (the first one is free).

Skills this job asks for

RecruitmentComplianceCommunicationConstruction managementAuditReconciliation

Add your CV (free) to see which of these your CV is missing.

Sponsorship verdict

Sponsorship possible

One solid signal, not two. Worth applying, and worth asking about sponsorship early.

  • Employer is on a government sponsor recordUSCIS Data Hub records 2 H-1B approvals for this employer in FY2023 — older 2023 data; no recent Department of Labor filings (Oct 2025 – Jun 2026) were found for it.
  • The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
  • No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
  • Confirmed live todayWhen a source last listed this job as open.
Details and sources
Employer is on a government sponsor record
USCIS Data Hub records 2 H-1B approvals for this employer in FY2023 — older 2023 data; no recent Department of Labor filings (Oct 2025 – Jun 2026) were found for it. Source: US Department of Labor visa filings (LCA) (US Department of Labor (OFLC), plus USCIS H-1B Employer Data Hub).
No salary bar for this route
H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.

US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).

A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.

About the role

Attention recruitment agencies: All agency inquiries are vetted through 4DMT’s internal Talent Acquisition team. No unsolicited resumes will be accepted. The 4DMT Talent Acquisition team must expressly engage agencies on any requisition. Agencies contacting hiring managers directly will not be tolerated, and doing so may impact your ability to work with 4DMT in the future. 4DMT is a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. The Company’s lead product candidate 4D-150 is designed to be a backbone therapy forming the foundation of treatment of blinding retinal vascular diseases by providing multi-year sustained delivery of anti-VEGF biologics (aflibercept and anti-VEGF-C) with a single intravitreal injection, which substantially reduces the treatment burden associated with current bolus injections. The Company’s lead indication for 4D-150 is wet age-related macular degeneration and the second indication is diabetic macular edema, which are both in Phase 3 development. The Company’s second product candidate is 4D-710, which is the first known genetic medicine to demonstrate successful delivery and expression of the CFTR transgene in the lungs of people with cystic fibrosis after aerosol delivery. We are taking genetic medicine to new heights and into new disease areas to overcome challenges not addressed by existing medicines. This incredible challenge drives our relentless and talented team. Our people are the essence of our inspiring, innovative and collaborative environment that encourages individual contributions and provides opportunities for career development. We seek the best in the industry who identify with our mission and our bold and innovative results-driven approach. Our Core Values drive the way we work together: • Dare to Cure • Break Boundaries • Beyond Yourself • Prepare & Execute Relentlessly Join us in creating the future of genetic medicine. GENERAL SUMMARY 4DMT seeks a motivated and detail-oriented In-House Clinical Research Associate (IHCRA) to support the Company’s clinical trial activities. This position reports to the Associate Director, Clinical Operations, and will support the day-to-day execution of a Phase 3 clinical trial, including study start-up, conduct, and close-out activities. The IHCRA will serve as a key liaison between 4DMT, clinical sites, and CRO partners, with a focus on site support, monitoring oversight, regulatory compliance, and data quality. This role requires strong written and verbal communication skills, excellent organizational skills, and the ability to manage competing priorities while delivering high-quality work in a fast-paced, team-oriented environment. MAJOR DUTIES & RESPONSIBILITIES: Clinical Trial Operations & Site Support • Support study execution across start-up, conduct, and close-out phases • Serve as a primary point of contact for assigned clinical sites and CRO field CRAs/monitors • Communicate directly with sites and CRO partners to obtain updates, resolve issues, and support study timelines • Support site initiation, ongoing site management, and site close-out activities • Assist with identification, documentation, tracking, and follow-up of site issues Monitoring Oversight • Support oversight of CRO monitoring activities • Review monitoring visit reports and follow up on action items and unresolved findings • Track monitoring deliverables and escalate issues to the Associate Director, Clinical Operations as appropriate • Support inspection readiness and audit activities Tracking & Study Oversight • Maintain accurate tracking tools for assigned studies, including: • Site start up and activation st

Apply on employer site ↗